France· FR:69316926
CLOROTEKAL 10 mg/ml, solution injectable
A medicinal product containing chlorhydrate de chloroprocaïne, registered in France by NORDIC GROUP (PAYS-BAS).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- CHLORHYDRATE DE CHLOROPROCAÏNE
- Manufacturer
- NORDIC GROUP (PAYS-BAS)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340092229586210 ampoule(s) en verre de 5 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Chlorhydrate de chloroprocaïne in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwitzerlandAmpres 10 mg/ml, soluzione iniettabileSintetica SA
- SpainAMPRES 10 MG/ML SOLUCION INYECTABLEB Braun Medical S.A.
- FinlandAmpresB. Braun Melsungen AG
- IrelandAmpres 10mg/ml solution for injectionB. Braun Melsungen AG
- NorwayAmpresB. Braun Melsungen AG
- PolandAmpresB. Braun Melsungen AG
- BelgiumAmpres 10 mg/mlNordic Group
- SwedenAmpres 10 mg/ml Injektionsvätska, lösningB. Braun Melsungen AG
Authorised across Europe · EMA
The same active substance is authorised in 21 EEA countries. Names it is sold under:
- Austria · Ampres, Visiclor
- Belgium · Ampres
- Bulgaria · Ампрес
- Germany · Ampres, Decelex
- Denmark · Ampres
- Estonia · Clorotekal
- Spain · Ampres
- Finland · Ampres
- United Kingdom (Northern Ireland) · Ampres
- Greece · Ampres
- Croatia · Clorotekal
- Hungary · Clorotekal
- Italy · Decelex
- Luxembourg · Ampres
- Latvia · Clorotekal
- Netherlands · Ampres
- Norway · Ampres
- Poland · Ampres
- Portugal · Ampres
- Sweden · Ampres
- Slovenia · Decelex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ecd76343-60e2-4ac3-9d15-dc03b51b42a1 GET /v1/drugs/ecd76343-60e2-4ac3-9d15-dc03b51b42a1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69316926",
"date_amm": "2012-11-12",
"type_amm": "Procédure décentralisée",
"numero_ue": null,
"substance": "CHLORHYDRATE DE CHLOROPROCAÏNE",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intrathécale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about chlorhydrate de chloroprocaïne.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.